These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30616617)

  • 1. TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol.
    Rachow A; Ivanova O; Wallis R; Charalambous S; Jani I; Bhatt N; Kampmann B; Sutherland J; Ntinginya NE; Evans D; Lönnroth K; Niemann S; Schaible UE; Geldmacher C; Sanne I; Hoelscher M; Churchyard G
    BMC Pulm Med; 2019 Jan; 19(1):4. PubMed ID: 30616617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in Africa.
    Evans D; van Rensburg C; Govathson C; Ivanova O; Rieß F; Siroka A; Sillah AK; Ntinginya NE; Jani I; Sathar F; Rosen S; Sanne I; Rachow A; Lönnroth K
    Glob Health Action; 2021 Jan; 14(1):1865625. PubMed ID: 33491593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
    Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
    Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of chronic lung impairment in Mozambican TB patients and associated risks.
    Khosa C; Bhatt N; Massango I; Azam K; Saathoff E; Bakuli A; Riess F; Ivanova O; Hoelscher M; Rachow A
    BMC Pulm Med; 2020 May; 20(1):127. PubMed ID: 32381002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UMOYA: a prospective longitudinal cohort study to evaluate novel diagnostic tools and to assess long-term impact on lung health in South African children with presumptive pulmonary TB-a study protocol.
    Dewandel I; van Niekerk M; Ghimenton-Walters E; Palmer M; Anthony MG; McKenzie C; Croucamp R; Alter G; Demers AM; van Zyl G; Claassen M; Goussard P; Swanepoel R; Hoddinott G; Bosch C; Dunbar R; Allwood B; McCollum ED; Schaaf HS; Hesseling AC; van der Zalm MM
    BMC Pulm Med; 2023 Mar; 23(1):97. PubMed ID: 36949477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors affecting treatment outcomes for pulmonary tuberculosis in Finland 2007-2014: a national cohort study.
    Korhonen V; Lyytikäinen O; Ollgren J; Soini H; Vasankari T; Ruutu P
    BMC Public Health; 2020 Aug; 20(1):1250. PubMed ID: 32807112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012.
    Choi H; Lee M; Chen RY; Kim Y; Yoon S; Joh JS; Park SK; Dodd LE; Lee J; Song T; Cai Y; Goldfeder LC; Via LE; Carroll MW; Barry CE; Cho SN
    BMC Infect Dis; 2014 Jul; 14():360. PubMed ID: 24990578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood TB sequel: evaluating respiratory function after treatment for pulmonary tuberculosis in a prospective cohort of Gambian children - a study protocol.
    Nkereuwem E; Agbla S; Jatta ML; Masterton U; Owolabi O; Edem VF; Kampmann B; Togun T
    BMC Pulm Med; 2023 Oct; 23(1):387. PubMed ID: 37828470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
    Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
    Gadallah MA; Mokhtar A; Rady M; El-Moghazy E; Fawzy M; Kandil SK
    J Formos Med Assoc; 2016 Nov; 115(11):997-1003. PubMed ID: 26696497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol.
    Myers B; Bouton TC; Ragan EJ; White LF; McIlleron H; Theron D; Parry CDH; Horsburgh CR; Warren RM; Jacobson KR
    BMC Infect Dis; 2018 Sep; 18(1):488. PubMed ID: 30268101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
    Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
    Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual lung damage after completion of treatment for multidrug-resistant tuberculosis.
    de Vallière S; Barker RD
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):767-71. PubMed ID: 15182148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study.
    Marambire ET; Banze D; Mfinanga A; Mutsvangwa J; Mbunda TD; Ntinginya NE; Celso K; Kallenius G; Calderwood CJ; Geldmacher C; Held K; Appalarowthu T; Rieß F; Panzner U; Heinrich N; Kranzer K;
    BMJ Open; 2022 Jul; 12(7):e060985. PubMed ID: 36427173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
    Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
    BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.